Brief: Herantis Pharma Applies For Delisting From Nasdaq First North Growth Market Sweden

Herantis Pharma Oyj

01/12/2022 09:55

Dec 1 (Reuters) - Herantis Pharma Oyj  HRTIS.HE :
    * HERANTIS PHARMA APPLIES FOR DELISTING REGARDING THE
SECONDARY
LISTING OF ITS SHARES FROM NASDAQ FIRST NORTH GROWTH MARKET
SWEDEN
    * LAST DAY OF TRADING ON NASDAQ FN GM SWEDEN IS EXPECTED TO
BE
JANUARY 31, 2023

Source text for Eikon:  ID:nWkr6T0ZSL 
Further company coverage:  HRTIS.HE 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))